Nanocarriers' entry into the cell: relevance to drug delivery.
about
Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now?Nanodelivery Systems as New Tools for Immunostimulant or Vaccine Administration: Targeting the Fish Immune SystemCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriersEngineered nanomaterial uptake and tissue distribution: from cell to organismEmerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsEfficient hepatic delivery of drugs: novel strategies and their significanceNanotechnology in bone tissue engineeringNanocarriers for vascular delivery of antioxidantsLocal viscoelasticity of living cells measured by rotational magnetic spectroscopy.Nanoparticles and intracellular applications of surface-enhanced Raman spectroscopyAutophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicityPotential toxicity of superparamagnetic iron oxide nanoparticles (SPION)Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A ReviewAnalysis of the influence of cell heterogeneity on nanoparticle dose responseReversion of pH-induced physiological drug resistance: a novel function of copolymeric nanoparticlesInfluence of the internalization pathway on the efficacy of siRNA delivery by cationic fluorescent nanodiamonds in the Ewing sarcoma cell modelCodelivery of chemotherapeutics via crosslinked multilamellar liposomal vesicles to overcome multidrug resistance in tumorBarriers to inhaled gene therapy of obstructive lung diseases: A reviewNew Delivery Systems of Stem Cells for Vascular Regeneration in IschemiaThe potential of magneto-electric nanocarriers for drug deliveryStimuli-Responsive Materials for Controlled Release of Theranostic Agents.Intracellular uptake and trafficking of difluoroboron dibenzoylmethane-polylactide nanoparticles in HeLa cells.Gene therapy in the cornea: 2005--present.Simulation of fusion-mediated nanoemulsion interactions with model lipid bilayers.Pulsed magneto-motive ultrasound imaging to detect intracellular trafficking of magnetic nanoparticles.Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism.The relationship between terminal functionalization and molecular weight of a gene delivery polymer and transfection efficacy in mammary epithelial 2-D cultures and 3-D organotypic culturesEpidermal growth factor receptor targeted nuclear delivery and high-resolution whole cell X-ray imaging of Fe3O4@TiO2 nanoparticles in cancer cells.Facile synthesis of multicompartment micelles based on biocompatible poly(3-hydroxyalkanoate).Construction and DNA condensation of cyclodextrin-coated gold nanoparticles with anthryl grafts.Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines.Nanodelivery in airway diseases: challenges and therapeutic applications.Polymeric nanocarriers for transport modulation across the pulmonary epithelium: dendrimers, polymeric nanoparticles, and their nanoblendsLipid-like materials for low-dose, in vivo gene silencingMacrophages offer a paradigm switch for CNS delivery of therapeutic proteins.The emergence of multiple particle tracking in intracellular trafficking of nanomedicines.Aggregation is a critical cause of poor transfer into the brain tissue of intravenously administered cationic PAMAM dendrimer nanoparticles.Effects of ligand distribution on receptor-diffusion-mediated cellular uptake of nanoparticles.Barrier capacity of human placenta for nanosized materials.
P2860
Q26739877-8B3B2876-80D8-4153-8342-077DCE597C8EQ26780430-85083D47-0B02-4638-9D02-9147A9CD8FD8Q26830028-DE52CEB7-605C-45BC-8C2E-81D9918EF317Q26852773-CF369117-0364-442E-8314-0BD0BC29E744Q26861914-A7C87272-669C-47CF-968B-1C7BA9D1D272Q26996159-8D447601-1469-47C9-8B53-3EB06785FF20Q27007518-39D6D8D1-12A1-4293-BB46-B530BBDE6038Q27008868-65E6CE00-E9B3-4EED-B428-05123D204572Q27027067-087087E4-1CBC-400D-BC5B-DCFDFD5B7D29Q27340138-19CD241B-54E3-4EEB-B832-D8FA27FB31D2Q28072486-CC6CB4CC-10C9-470A-AE05-C30B2224C655Q28388552-7F3C5D7F-81D1-436B-B248-4CCED6BCC292Q28393651-E2C775F4-CACF-46AF-AABF-19E47542AC27Q28394719-049C19EE-9758-4746-8A09-71D50DD230ACQ28396936-8C54B8AD-1484-4D32-937A-A0FE280EE744Q28477221-5F79FD34-55E3-4396-8A70-C7D3C429F8A1Q28484469-DFA6673A-D879-47FD-AB51-330A4F76EDC9Q28543911-D8D419A3-6ED3-4613-8D3C-EED4F41F56A1Q29248141-560693B6-26EA-4249-91C2-78CF73F7DC08Q30361288-0A715755-5F45-4A27-BCEA-FE85CF59D4D0Q30403718-84089B46-713F-48E7-AC1F-56C233C5F11BQ30406730-C2AF97CE-0769-4482-94D5-9F1FA38B5C8CQ30432232-C7AA311E-F59F-43DD-97E8-95D183BD6940Q30459643-8DE98578-0C13-4269-8E31-59A648BB3ECFQ30459662-D0D7B758-B17C-4E54-BB32-337D66D59CD6Q30462494-5B8F191D-3162-46BB-AE62-D4A6D7E51C95Q30501687-77E7A36C-1BF3-4A15-B93C-FDBC73EA89D6Q30504481-225D56C2-D935-455A-86DA-0A7DFBC009AEQ30571353-CCEEB845-B85A-4D7F-8FBF-E09C7167708DQ30581548-B90A4DD0-03C9-4B20-AE61-07D9CC4AF1FBQ30826766-B5813A80-A8C5-47E1-96D7-6903267E0BE8Q30898130-45C8AC53-D2EA-4892-BC6D-D79DE71F6CAEQ33483926-86480891-EF8D-4F2E-9D44-F411505E0C23Q33574188-28B6CB1B-AEC4-46F9-AD36-02D78B5A457EQ33583399-1330EADE-D6D4-44F4-BD6A-BEBCA31F04C3Q33631069-5A512C29-5AAE-4C43-AE35-365AF2B8DD40Q33639580-133902C1-12EE-4A52-BBA6-99A77F1F4FF7Q33739963-5A949D68-6EBB-4E1C-8865-5982C78AF18AQ33748118-11B3602B-2D11-4C5B-AB69-CE62A4AABF3AQ33789969-B6C7492C-1403-49E4-8BA1-063784C44F94
P2860
Nanocarriers' entry into the cell: relevance to drug delivery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanocarriers' entry into the cell: relevance to drug delivery.
@en
Nanocarriers' entry into the cell: relevance to drug delivery.
@nl
type
label
Nanocarriers' entry into the cell: relevance to drug delivery.
@en
Nanocarriers' entry into the cell: relevance to drug delivery.
@nl
prefLabel
Nanocarriers' entry into the cell: relevance to drug delivery.
@en
Nanocarriers' entry into the cell: relevance to drug delivery.
@nl
P2860
P1476
Nanocarriers' entry into the cell: relevance to drug delivery.
@en
P2093
Hervé Hillaireau
P2860
P2888
P304
P356
10.1007/S00018-009-0053-Z
P577
2009-06-05T00:00:00Z